Debt to Equity Ratio Chart

View Debt to Equity Ratio for TFX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.989
March 31, 2026 0.8707
December 31, 2025 0.8723
September 30, 2025 0.7246
June 30, 2025 0.4702
March 31, 2025 0.4896
December 31, 2024 0.4076
September 30, 2024 0.4153
June 30, 2024 0.3994
March 31, 2024 0.4137
December 31, 2023 0.4382
September 30, 2023 0.4982
June 30, 2023 0.3963
March 31, 2023 0.4264
December 31, 2022 0.4603
September 30, 2022 0.464
June 30, 2022 0.4726
March 31, 2022 0.5165
December 31, 2021 0.5295
September 30, 2021 0.5918
June 30, 2021 0.6952
March 31, 2021 0.7283
December 31, 2020 0.7754
September 30, 2020 0.6857
June 30, 2020 0.8083
Date Value
March 31, 2020 0.8106
December 31, 2019 0.6818
September 30, 2019 0.7443
June 30, 2019 0.8436
March 31, 2019 0.8874
December 31, 2018 0.8499
September 30, 2018 0.8588
June 30, 2018 0.9172
March 31, 2018 0.8716
December 31, 2017 0.9255
September 30, 2017 0.91
June 30, 2017 0.8479
March 31, 2017 0.9414
December 31, 2016 0.4843
September 30, 2016 0.4755
June 30, 2016 0.5105
March 31, 2016 0.5226
December 31, 2015 0.5305
September 30, 2015 0.5481
June 30, 2015 0.5798
March 31, 2015 0.5929
December 31, 2014 0.559
September 30, 2014 0.5376
June 30, 2014 0.5359
March 31, 2014 0.6637

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Globus Medical, Inc. 0.0235
Boston Scientific Corp. 0.5064
Alphatec Holdings, Inc. 52.37
CONMED Corp. 0.8011
DexCom, Inc. 0.5335